search results for: AstraZeneca

Take­da’s new deal with Kumquat; IL-2 biotech rais­es $55M

2 hours ago
News Briefing

Ver­tex's $4.9B bet; Lay­offs at No­var­tis, Genen­tech, Sanofi; Star founders un­veil new star­tups; and more

3 days ago
Weekly

EMA probe finds no causal link be­tween semaglu­tide and sui­ci­dal thoughts, self-harm

3 days ago
Pharma
FDA+

ADC deal­mak­ing is red hot. Is it sus­tain­able?

4 days ago
Deals
Pharma

As­traZeneca's Fasen­ra ex­pands ap­proval in chil­dren with se­vere asth­ma

4 days ago
Pharma
FDA+

Lights, cam­era and com­mu­ni­ty: As­traZeneca’s Alex­ion cre­ates an orig­i­nal film to spot­light rare neu­ro­log­i­cal ...

5 days ago
Pharma
Marketing

As­traZeneca's ‘ra­diosen­si­tiz­er’ may en­hance ef­fi­ca­cy of ra­di­a­tion for dead­ly brain can­cer: #AACR24

6 days ago
R&D

Mon­sters, di­nosaurs and su­per­heroes: Why phar­ma is bring­ing char­ac­ters back in­to the ad mix 

Last week
Pharma
Marketing

As­traZeneca eyes a safer PARP in­hibitor, with near­ly 50% re­sponse in ad­vanced breast can­cer pa­tients: #AACR24

Last week
R&D

Io­n­is presents piv­otal rare dis­ease da­ta, builds to­ward first so­lo launch: #ACC24

Last week
R&D

US-Chi­na ten­sions per­sist; Gen­mab's $1.8B ADC bet; New obe­si­ty start­up in town; ALS drug with­draw­al; and more

Last week
Weekly

FDA grants En­her­tu tu­mor-ag­nos­tic ac­cel­er­at­ed ap­proval

Last week
Pharma
FDA+

As­traZeneca un­veils pos­i­tive Phase 3 da­ta to move Imfinzi in­to ear­li­er stages of lung can­cer

Last week
R&D
Pharma

For­eign in­vestors fled Chi­nese biotech af­ter the pan­dem­ic. They still haven’t come back

Last week
Financing
China

As Mer­ck KGaA grows South Ko­re­an foot­print, it al­so ze­roes in on re­gion­al man­u­fac­tur­ing

Last week
Manufacturing

Fi­bro­Gen eyes re­bound path with Ph1 ADC da­ta for prostate can­cer drug

Last week
R&D

Al­terome rais­es $132M to take next-gen can­cer drugs aimed at the 'un­drug­gable' in­to clin­ic

Last week
Financing
R&D

Gen­mab fu­els AD­C­s' hot streak with $1.8B buy­out of Pro­found­Bio

Last week
Deals
1234 Next page Last page

latest

Most read

Boehringer In­gel­heim touts 10-year plan as it eyes over­tak­ing Bay­er as Ger­many’s largest phar­ma

5 hours ago
Pharma

How drug­mak­ers are han­dling new pres­sure to re­cy­cle plas­tic in­jec­tion pens as mil­lions of new pa­tients be­gin us­ing ...

14 minutes ago
Pharma
Marketing

In lat­est turn to au­toim­mune ther­a­pies, Cul­li­nan nabs $280M to join lu­pus space

1 hour ago
Financing
R&D

Take­da’s new deal with Kumquat; IL-2 biotech rais­es $55M

2 hours ago
News Briefing

In­tra-Cel­lu­lar on track for an­oth­er Caply­ta la­bel ex­pan­sion af­ter pos­i­tive Ph3 de­pres­sion da­ta

2 hours ago
R&D
see latest stream
A service from the Financial Times